-+ 0.00%
-+ 0.00%
-+ 0.00%

NEONC TECHNOLOGIES HOLDINGS, INC. EXPECTS FULL ENROLLMENT IN PROMISING PHASE 2A TRIAL OF NEO100-01 FOR MALIGNANT GLIOMAS IN SEPTEMBER

Reuters·04/14/2025 12:05:00

Please log in to view news